Patient happy to accept the small benefits of additional ezetimibe post-ACS

+Print Archive
Practice

Patient happy to accept the small benefits of additional ezetimibe post-ACS

Chris Ellis

Chris Ellis

bpm

A second stent placement after a myocardial infarction requires this patient to consider more aggressive lipid management. Cardiologist Chris Ellis looks at the evidence for the non-statin drug ezetimibe

A 62-year-old businessman comes in for review four months after a hospital discharge. He had been admitted with an anterior-lateral non-ST elevation m